儿童难治性癫痫的医用大麻：综述
Medical Cannabis for Intractable Epilepsy in Childhood: A Review.
作者信息
Ben-Zeev Bruria
机构信息
Pediatric Neurology Department, The Edmond and Lilly Safra Pediatric Hospital, Sheba Medical Center, Tel Hashomer, Israel.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
出版信息
Rambam Maimonides Med J. 2020 Jan 30;11(1):e0004. doi: 10.5041/RMMJ.10387.
Abstract
In recent years, cannabis has been gaining increasing interest in both the medical research and clinical fields, with regard to its therapeutic effects in various disorders. One of the major fields of interest is its role as an anticonvulsant for refractory epilepsy, especially in the pediatric population. This paper presents and discusses the current accumulated knowledge regarding artisanal cannabis and Epidiolex®, a United States Food and Drug Administration (FDA)-approved pure cannabidiol (CBD), in epilepsy management in pediatrics, by reviewing the literature and raising debate regarding further research directions.
摘要
近年来，大麻因其在各种疾病中的治疗作用，在医学研究和临床领域都越来越受到关注。其中一个主要的关注领域是其作为难治性癫痫抗惊厥药物的作用，尤其是在儿科人群中。本文通过回顾文献并引发关于进一步研究方向的讨论，介绍并讨论了目前关于手工制作大麻和美国食品药品监督管理局（FDA）批准的纯大麻二酚（CBD）药物Epidiolex®在儿科癫痫治疗中的积累知识。
相似文献
1
Medical Cannabis for Intractable Epilepsy in Childhood: A Review.儿童难治性癫痫的医用大麻：综述
Rambam Maimonides Med J. 2020 Jan 30;11(1):e0004. doi: 10.5041/RMMJ.10387.
2
Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.大麻二酚手工制剂治疗癫痫的疗效：三级医疗中心的实践经验。
Epilepsy Behav. 2018 Mar;80:240-246. doi: 10.1016/j.yebeh.2018.01.026. Epub 2018 Feb 9.
3
Medical Marijuana in the Pediatric Population With Epilepsy-What You Should Know.儿童癫痫患者使用医用大麻——您应该知道的事。
J Pediatr Health Care. 2019 Nov-Dec;33(6):626-632. doi: 10.1016/j.pedhc.2019.03.002. Epub 2019 Jun 1.
4
Cannabis for the Treatment of Epilepsy: an Update.大麻治疗癫痫：最新进展。
Curr Neurol Neurosci Rep. 2018 Sep 8;18(11):73. doi: 10.1007/s11910-018-0882-y.
5
Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects.Epidiolex作为难治性癫痫治疗的辅助疗法：一项聚焦于不良反应的综述
F1000Res. 2019 Feb 28;8. doi: 10.12688/f1000research.16515.1. eCollection 2019.
6
The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.大麻（ marijuana ）和大麻二酚（ CBD ）在美国法律下的法律地位。
Epilepsy Behav. 2017 May;70(Pt B):288-291. doi: 10.1016/j.yebeh.2016.11.021. Epub 2017 Feb 4.
7
Medical Cannabis in Children.儿童医用大麻
Rambam Maimonides Med J. 2020 Jan 30;11(1):e0003. doi: 10.5041/RMMJ.10386.
8
Cannabidiol as potential treatment in refractory pediatric epilepsy.大麻二酚作为难治性小儿癫痫的潜在治疗方法。
Expert Rev Neurother. 2016;16(1):17-21. doi: 10.1586/14737175.2016.1121098. Epub 2015 Dec 9.
9
Cannabinoids in treatment-resistant epilepsy: A review.大麻素类药物在难治性癫痫治疗中的应用综述
Epilepsy Behav. 2017 May;70(Pt B):341-348. doi: 10.1016/j.yebeh.2016.11.012. Epub 2017 Feb 8.
10
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience.富含大麻二酚的医用大麻治疗儿童难治性癫痫：以色列的当前经验
Seizure. 2016 Feb;35:41-4. doi: 10.1016/j.seizure.2016.01.004. Epub 2016 Jan 6.
引用本文的文献
1
Use of Cannabis-Based Medical Products for Pediatric Health Conditions: A Systematic Review of the Recent Literature.基于大麻的医疗产品用于儿童健康状况：近期文献的系统评价
Med Cannabis Cannabinoids. 2024 Dec 10;7(1):257-267. doi: 10.1159/000542550. eCollection 2024 Jan-Dec.
2
New Pharmacological Therapies in the Treatment of Epilepsy in the Pediatric Population.治疗儿童癫痫的新型药物疗法
J Clin Med. 2024 Jun 18;13(12):3567. doi: 10.3390/jcm13123567.
3
Real-World Evidence of Factors Affecting Cannabidiol Exposure in Children with Drug-Resistant Developmental and Epileptic Encephalopathies.影响耐药性发育性和癫痫性脑病患儿大麻二酚暴露因素的真实世界证据
Pharmaceutics. 2023 Aug 10;15(8):2120. doi: 10.3390/pharmaceutics15082120.
4
Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy-Analysis from the UK Medical Cannabis Registry.英国医用大麻注册中心：治疗耐药性癫痫的大麻基药物治疗儿童的临床转归数据分析。
Neuropediatrics. 2023 Jun;54(3):174-181. doi: 10.1055/a-2002-2119. Epub 2022 Dec 20.
5
School Nurse Perspectives of Medical Cannabis Policy in K-12 Schools: An Exploratory Descriptive Study.中小学医学生大麻政策的学校护士观点：探索性描述性研究。
J Sch Nurs. 2024 Dec;40(6):596-607. doi: 10.1177/10598405221136288. Epub 2022 Nov 14.
6
Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis.医用大麻素治疗儿童疾病的疗效和安全性：系统评价和荟萃分析。
Sci Rep. 2021 Dec 6;11(1):23462. doi: 10.1038/s41598-021-02770-6.
7
Cardiac Transplantation and the Use of Cannabis.心脏移植与大麻的使用。
Life (Basel). 2021 Oct 9;11(10):1063. doi: 10.3390/life11101063.
本文引用的文献
1
The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study.PTL-101，一种口服大麻二酚制剂，在儿科难治性癫痫中的安全性、耐受性和有效性：一项 II 期、开放标签、单中心研究。
Epilepsy Behav. 2019 Sep;98(Pt A):233-237. doi: 10.1016/j.yebeh.2019.07.007. Epub 2019 Aug 5.
2
Effects of cannabidiol on brivaracetam plasma levels.大麻二酚对布瓦西坦血浆水平的影响。
Epilepsia. 2019 Jul;60(7):e74-e77. doi: 10.1111/epi.16071. Epub 2019 Jun 18.
3
Potential Clinical Benefits of CBD-Rich Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis.富含大麻二酚（CBD）的提取物相较于纯化CBD在难治性癫痫治疗中的潜在临床益处：观察性数据荟萃分析
Front Neurol. 2018 Sep 12;9:759. doi: 10.3389/fneur.2018.00759. eCollection 2018.
4
On the Preparations of the Indian Hemp, or Gunjah (Cannabis Indica), Their Effects on the Animal System in Health, and Their Utility in the Treatment of Tetanus and Other Convulsive Diseases.论印度大麻（即印度大麻脂，学名Cannabis Indica）的制剂、其对健康动物机体的作用及其在治疗破伤风和其他惊厥性疾病中的效用
Br Foreign Med Rev. 1840 Jul;10(19):225-228.
5
Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results.长期使用大麻二酚治疗耐药性癫痫儿童和成人的安全性和疗效：扩展使用项目结果。
Epilepsia. 2018 Aug;59(8):1540-1548. doi: 10.1111/epi.14477. Epub 2018 Jul 12.
6
Quality Traits of "Cannabidiol Oils": Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations.“大麻二酚油”的质量特征：欧洲市售制剂的大麻素含量、萜烯图谱和氧化稳定性。
Molecules. 2018 May 20;23(5):1230. doi: 10.3390/molecules23051230.
7
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.大麻二酚对 Lennox-Gastaut 综合征癫痫发作的影响。
N Engl J Med. 2018 May 17;378(20):1888-1897. doi: 10.1056/NEJMoa1714631.
8
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.Dravet 综合征中大麻二酚的随机、剂量范围安全性试验。
Neurology. 2018 Apr 3;90(14):e1204-e1211. doi: 10.1212/WNL.0000000000005254. Epub 2018 Mar 14.
9
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.Lennox-Gastaut 综合征相关癫痫患儿中使用大麻二酚治疗的随机、双盲、安慰剂对照 3 期临床试验（GWPCARE4）
Lancet. 2018 Mar 17;391(10125):1085-1096. doi: 10.1016/S0140-6736(18)30136-3. Epub 2018 Jan 26.
10
Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.大麻二酚可减轻 Dravet 综合征小鼠模型的癫痫发作和社交障碍。
Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11229-11234. doi: 10.1073/pnas.1711351114. Epub 2017 Oct 2.
Zotero 插件